Similarly, we found that SFMBT2 acts as a transcriptional repressor of TNFα gene expression and knockdown of SFMBT2 results in increased expression of TNFα, which activates the NF-κB signaling and plays an important role in prostate cancer progression (Figure S6) [84,85,86]. This evidence concerns the gene TNF and prostate carcinoma.